Prokineticin-izing Doxorubicin-Damaged Hearts
JACC CardioOncol
.
2019 Sep 24;1(1):103-104.
doi: 10.1016/j.jaccao.2019.08.009.
eCollection 2019 Sep.
Author
Emilio Hirsch
1
Affiliation
1
Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
PMID:
34396167
PMCID:
PMC8352256
DOI:
10.1016/j.jaccao.2019.08.009
No abstract available
Keywords:
PI3K/Akt pathway; cardiotoxicity; doxorubicin; prokineticin.
Publication types
Editorial